Spero Biopharma

Spero Biopharma Israeli Company

Spero Biopharma is the developer of Ladostigil, a drug designed to treat mild cognitive impairment before it progresses to Alzheimer's disease.

Health Tech & Life Sciences Biopharma Biotechnology Health Care Wellness

Alternatives

No alternatives listed yet.

Suggest an Alternative

Office Locations

Ramat Hasharon, Israel

References

[1]
finder.startupnationcentral.org - https://finder.startupnationcentral.org/company_page/spero-biopharma
[2]
crunchbase.com - https://www.crunchbase.com/organization/spero-biopharma

External links are provided for reference and verification purposes.